Submitted by dcc on Fri, 2019-06-14 09:08 Study Title: Phase I/II Study of Pamiparib (BGB-290) with Temozolomide in Recurrent Gliomas with IDH1/2 MutationsCIRB: Adult CIRB - Early Phase EmphasisLead Group: ABTCStatus: ActiveReview Status: Available to Open
